ALPHARETTA, Ga. , June 9, 2025 /PRNewswire/ -- Avanos Medical, Inc. (NYSE: AVNS) a leading medical technology company focused on delivered innovative healthcare solutions, today announced the appointment of Camille Chang Gilmore as senior vice president and chief human resources officer.
Avanos Medical, Inc. (NYSE:AVNS ) Q1 2025 Earnings Conference Call May 6, 2025 9:00 AM ET Company Participants Scott Galovan - Vice President of Strategy and Corporate Development Dave Pacitti - Chief Executive Officer Jason Pickett - Interim Chief Financial Officer and Treasurer Conference Call Participants Rick Wise - Stifel Daniel Stauder - Citizens JMP Operator Good morning, ladies and gent...
ALPHARETTA, Ga. , April 28, 2025 /PRNewswire/ -- Avanos Medical, Inc. (NYSE: AVNS) will webcast its conference call discussing financial results and business highlights for the first quarter 2025 on Tuesday, May 6 at 9 a.m.
ZAVENTEM, Belgium , April 2, 2025 /PRNewswire/ -- Avanos Medical, Inc. (NYSE: AVNS) a global medical technology company, today announced that it will take direct responsibility for the sales and distribution of its MIC-KEY enteral feeding products in the United Kingdom, effective 25 July 2025. This strategic move reflects Avanos' commitment to prioritizing customer needs, enhancing product avai...
ALPHARETTA, Ga. , March 17, 2025 /PRNewswire/ -- Avanos Medical, Inc. (NYSE: AVNS), a leading medical technology company, today announced the appointment of David Pacitti as its new chief executive officer, effective April 14, 2025.
Avanos Medical Inc. (NYSE:AVNS ) Q4 2024 Earnings Conference Call February 26, 2025 9:00 AM ET Company Participants Scott Galovan - Vice President of Strategy & Corporate Development Michael Greiner - Interim Chief Executive Officer Conference Call Participants Danny Stauder - Citizens GMP Operator Good morning ladies and gentlemen. Welcome to the Avanos Fourth Quarter 2024 Earnings Call.
aktien.guide ist das Tool zum einfachen Finden, Analysieren und Beobachten von Aktien. Lerne von erfolgreichen Investoren und triff fundierte Anlageentscheidungen. Wir machen Dich zum selbstbestimmten Investor.